English press releases

Budweiser Heralds the Return of FIFA World Cup™ With Global Campaign Declaring “The World is Yours to Take”

Budweiser, the Official Beer of the FIFA World Cup™, teams up with Messi, Neymar Jr., and Sterling to inspire fans to seize greatness LEUVEN, Belgium–(BUSINESS...

ADVA launches auto-tunable transceiver to help operators easily scale access networks to 25G

News summary: Higher bandwidth services are urgently required in mobile fronthaul and cable access networks ADVA AccesWave25™ offers an easy way to boost existing 10G...

Ownera Announces $20M Series A Financing including J.P. Morgan and LRC Group

Funding will be used to accelerate Ownera’s deployment of a global interoperability network to unlock the institutional tokenized securities market. LONDON–(BUSINESS WIRE)– Ownera, the company...

Philip Morris International Announces Appointment of Two Former U.S. FDA Officials, Highlighting the Company’s Continued Commitment to Smoke-Free Product Science and Regulation

Dr. Badrul Chowdhury Appointed Chief Life Sciences Officer Dr. Matthew Holman Appointed Vice President, U.S. Scientific Engagement and Regulatory Strategy WASHINGTON–(BUSINESS WIRE)– Philip Morris International...

Six Upgrades to Guarantee L4 Self-Driving Operation! RoboSense Upgraded 128-beam LiDAR RS-Ruby Plus

SHENZHEN, China–(BUSINESS WIRE)– RoboSense, a world-leading provider of Smart LiDAR Sensor Systems launched upgraded 128-beam LiDAR, RS-Ruby Plus, designed for autonomous driving commercial operation, and...

GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease

Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD) Trial also met its first key secondary...

Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer

Submissions based on data from the Phase 3 ATHENA trial evaluating Rubraca monotherapy versus placebo (ATHENA-MONO) presented at ASCO 2022 The ATHENA-MONO trial met its...

ONWARD Reports Positive Topline Results from a Pivotal Study to Restore Arm and Hand Function in People With Spinal Cord Injury

Up-LIFT study achieves primary endpoint: Statistically significant and clinically meaningful improvement in upper extremity strength and functioni Improvement in arm and hand function is the...

Bright Data to Launch Bright Insights, with the Acquisition of Top eCommerce Digital Analytics Provider Market Beyond

With Bright Insights, Bright Data will now provide customers with the complete web data cycle, from collection through to analysis and actionable insights LONDON–(BUSINESS WIRE)–...

Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer

Results from the primary analysis of the SUNLIGHT trial to be presented at an upcoming scientific conference PARIS–(BUSINESS WIRE)– Servier, Taiho Oncology, Inc., and Taiho...

Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups

Subgroup analysis from the Phase 3 ATHENA trial evaluating Rubraca monotherapy versus placebo (ATHENA-MONO) presented in a Mini Oral session at the ESMO Congress 2022...

May Health Solidifies Veteran Executive Team with Appointment of Women’s Health Care Leader Anne Morrissey as CEO

– Renowned reproductive health expert Dr. Robert Auerbach, OBGYN, appointed chairman of the board – May Health, formerly AblaCare, changes its name to reflect focus...

Rimini Street Earns Additional Great Place to Work® Certifications in US, Australia and New Zealand

Rimini Street is now globally recognized by its employees for building an inclusive, high trust, high-performance culture with career growth and development opportunities for all...

Vertex Appoints Jonathan Biller as Chief Legal Officer

BOSTON–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jonathan Biller has been appointed Chief Legal Officer, effective September 19, 2022. Mr. Biller will...

ADVA introduces new 10G edge device for outdoor environments

News summary: Demand is rising for 10Gbit/s MEF 3.0 Carrier Ethernet in a wide range of locations Service providers need high-performance demarcation technology optimized for...